Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Nausea and Vomiting; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell TumorInterventions: Drug: Aprepitant; Drug: Cyclophosphamide; Drug: Dexamethasone; Drug: Granisetron hydrochlorideSponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chronic Myeloproliferative Neoplasm | Dexamethasone | Gestational Trophoblastic Tumor | Leukemia | Lymphoma | Neuroblastoma | Neurology | Research | Stem Cell Therapy | Stem Cells | Transplants